AdaptHealth Corp. (AHCO)
$
10.84
+0.20 (1.85%)
Key metrics
Financial statements
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
AdaptHealth Corp., along with its subsidiaries, plays a pivotal role in providing home medical equipment (HME), medical supplies, and a variety of related services across the United States. The company specializes in delivering essential sleep therapy equipment and supplies, including CPAP and bi-PAP services, catering to individuals afflicted with obstructive sleep apnea. It also offers vital medical devices such as continuous glucose monitors and insulin pumps for diabetes management, alongside HME for patients transitioning from acute care facilities. Additionally, AdaptHealth facilitates oxygen and related chronic therapy services at home, and supplies HME devices for individuals with chronic conditions requiring wound care, urological assistance, incontinence solutions, ostomy products, and nutritional support. The net total of other income and expenses is -$127,713,000.00 reflecting non-core financial activities tied to the business. The EBITDA ratio is 0.09 highlighting the company’s operational efficiency in managing its resources. Moreover, the total costs and expenses for the company amount to $2,997,243,000.00 indicating its overall spending habits within the healthcare sector. The weighted average number of shares outstanding is 133,756,000.00 showcasing the scale of the company's shareholder base. Finally, the income before tax ratio is 0.04 which reflects the pre-tax margin and underlying profitability. From an investment perspective, the stock is affordable at $10.74 making it suitable for budget-conscious investors looking for accessible opportunities in the market. With an average trading volume of 1,501,958.00 the stock indicates a moderate level of liquidity, suggesting a reasonable ease of transaction for investors. Furthermore, with a market capitalization of $1,461,958,280.00 the company is classified as a small-cap player within the broader market. AdaptHealth Corp. is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape with its innovative solutions. Additionally, it belongs to the Healthcare sector, driving innovation and growth, which positions it favorably for future opportunities.
Investing in AdaptHealth Corp. (AHCO) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict AdaptHealth Corp. stock to fluctuate between $8.35 (low) and $11.90 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-04-02, AdaptHealth Corp.'s market cap is $1,461,958,280, based on 134,867,000 outstanding shares.
Compared to Meta Platforms, Inc. Class A Common Stock, AdaptHealth Corp. has a Lower Market-Cap, indicating a difference in performance.
To buy AdaptHealth Corp. (AHCO) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AHCO. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Revenue: $3,260,975,000 | EPS: $0.68 | Growth: -112.78%.
Visit https://adapthealth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $41.58 (2021-02-01) | All-time low: $6.37 (2023-11-08).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
AdaptHealth Corp specializes in sleep therapy equipment and respiratory health. These two focus segments also command the best margins for the company. Q4 2024 results exceeded expectations, driving a 30% stock surge; the company reported a record 12.3% operating income margin.
zacks.com
Investors interested in Medical - Products stocks are likely familiar with AdaptHealth Corp. (AHCO) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
zacks.com
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
seekingalpha.com
AdaptHealth Corp. (NASDAQ:AHCO ) Q4 2024 Earnings Conference Call February 25, 2025 8:30 AM ET Company Participants Suzanne Foster – Chief Executive Officer Jason Clemens – Chief Financial Officer Conference Call Participants Ben Hendrix – RBC Capital Markets Mathew Blackman – Stifel Brian Tanquilut – Jefferies Richard Close – Canaccord Eric Coldwell – Baird Kieran Ryan – Deutsche Bank Operator Good day, everyone and welcome to today's AdaptHealth Fourth Quarter 2024 Earnings Release. Today's speakers will be Suzanne Foster, Chief Executive Officer of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth.
zacks.com
AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.64 per share a year ago.
zacks.com
The heavy selling pressure might have exhausted for AdaptHealth (AHCO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
zacks.com
Investors looking for stocks in the Medical - Products sector might want to consider either AdaptHealth Corp. (AHCO) or Abbott (ABT). But which of these two stocks is more attractive to value investors?
zacks.com
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
See all news